Vapotherm (NYSE:VAPO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing […]
Vapotherm (NYSE:VAPO – Get Rating) and USA Equities (OTCMKTS:USAQ – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership. Profitability This table compares Vapotherm and USA Equities’ net margins, […]
Vapotherm (NYSE:VAPO – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing […]
Vapotherm (NYSE:VAPO – Get Rating) had its target price reduced by research analysts at Canaccord Genuity Group from $21.00 to $12.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective points to a potential upside of 82.37% from the […]
Vapotherm (NYSE:VAPO – Get Rating) had its target price cut by stock analysts at Canaccord Genuity Group from $21.00 to $12.00 in a research report issued on Wednesday, The Fly reports. Canaccord Genuity Group’s price objective indicates a potential upside of 92.93% from the company’s current price. VAPO has been the topic of a number […]